MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: net inventory
Net inventory for MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. financial histories
What this measure means
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
Exact concept: us-gaap:InventoryNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 1,704,309 | USD | 2026-04-29 | 20-F · 0001213900-26-049081 |
| At date | 2024-12-31 | 1,409,639 | USD | 2026-04-29 | 20-F · 0001213900-26-049081 |
| At date | 2023-12-31 | 1,617,225 | USD | 2025-04-25 | 20-F · 0001213900-25-035216 |
| At date | 2022-12-31 | 1,122,038 | USD | 2024-04-24 | 20-F · 0001213900-24-035784 |
| At date | 2021-12-31 | 1,251,393 | USD | 2023-08-29 | 20-F/A · 0001213900-23-071440 |
| At date | 2020-12-31 | 1,326,090 | USD | 2022-07-29 | 20-F · 0001213900-22-042817 |
Related financial histories
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: total assets
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: total liabilities
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: stockholders equity
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: cash and cash equivalents
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: net income or loss
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: operating cash flow
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: capital expenditure payments
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: revenue
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: financing cash flow
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: investing cash flow
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: retained earnings or deficit
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: basic weighted-average shares
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: diluted weighted-average shares
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: basic earnings per share
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: diluted earnings per share
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: income tax expense or benefit
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: net property, plant and equipment
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: operating income or loss
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: current assets
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: current liabilities
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: current accounts payable
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: net finite-lived intangible assets
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: net current accounts receivable
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: operating expenses
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: gross profit
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: cost of revenue
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD.: research and development expense
Inspect the source
- Entity
- MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. / CIK 0001835615
- Captured
- 2026-09-21T17:36:44.502Z
- SEC response SHA-256
0672338a0f4b13b17d54dc76b33fac931920b6061cb0c472c5290b045a207804
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001835615.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))